Literature DB >> 23640157

Localization of the gene for hyperostosis cranialis interna to chromosome 8p21 with analysis of three candidate genes.

V M Borra1, J J Waterval, R J Stokroos, J J Manni, W Van Hul.   

Abstract

Hyperostosis cranialis interna (HCI) is a rare autosomal dominant disorder characterized by intracranial hyperostosis and osteosclerosis, which is confined to the skull, especially the calvarium and the skull base. The rest of the skeleton is not affected. Progressive bone overgrowth causes nerve entrapment that leads to recurrent facial nerve palsy, disturbance of the sense of smell, hearing and vision impairments, impairment of facial sensibility, and disturbance of balance due to vestibular areflexia. The treatment is symptomatic. Histomorphological investigations showed increased bone formation with a normal tissue structure. Biochemical parameters were normal. Until today the disease has been described in only three related Dutch families with common progenitors and which consist of 32 individuals over five generations. HCI was observed in 12 family members over four generations. Patients are mildly to severely affected. Besides HCI, several bone dysplasias with hyperostosis and sclerosis of the craniofacial bones are known. Examples are Van Buchem disease, sclerosteosis, craniometaphyseal dysplasia, and Camurati-Engelmann disease. However, in these cases the long bones are affected as well. Linkage analysis in a family with HCI resulted in the localization of the disease-causing gene to a region on chromosome 8p21 delineated by markers D8S282 and D8S382. Interesting candidate genes in this region are BMP1, LOXL2, and ADAM28. Sequence analysis of these genes did not reveal any putative mutations. This suggests that a gene not previously involved in a sclerosing bone dysplasia is responsible for the abnormal growth in the skull of these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640157     DOI: 10.1007/s00223-013-9732-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

Review 1.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

2.  Genetic basis of hyperostosis cranialis interna.

Authors: 
Journal:  Bonekey Rep       Date:  2013-09-11

3.  Progress and challenges in the computational prediction of gene function using networks: 2012-2013 update.

Authors:  Paul Pavlidis; Jesse Gillis
Journal:  F1000Res       Date:  2013-10-31

4.  Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4+ T Lymphocyte Depletion in Treated HIV Infection.

Authors:  Sophie Seang; Anoma Somasunderam; Maitreyee Nigalye; Ma Somsouk; Timoty W Schacker; Joyce L Sanchez; Peter W Hunt; Netanya S Utay; Jordan E Lake
Journal:  Pathog Immun       Date:  2017-06-21

5.  Conditional mouse models support the role of SLC39A14 (ZIP14) in Hyperostosis Cranialis Interna and in bone homeostasis.

Authors:  Gretl Hendrickx; Vere M Borra; Ellen Steenackers; Timur A Yorgan; Christophe Hermans; Eveline Boudin; Jérôme J Waterval; Ineke D C Jansen; Tolunay Beker Aydemir; Niels Kamerling; Geert J Behets; Christine Plumeyer; Patrick C D'Haese; Björn Busse; Vincent Everts; Martin Lammens; Geert Mortier; Robert J Cousins; Thorsten Schinke; Robert J Stokroos; Johannes J Manni; Wim Van Hul
Journal:  PLoS Genet       Date:  2018-04-05       Impact factor: 5.917

6.  Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.

Authors:  Li Wei; Jing-Yun Wen; Jie Chen; Xiao-Kun Ma; Dong-Hao Wu; Zhan-Hong Chen; Jiang-Long Huang
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.